Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole-Reference-Cited by-同舟云学术

Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole

Published:2007-04-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Lin Daren¹,Li Wing-Ki²,Rieder Michael J³

Affiliation:

1. University of Western Ontario; London ON Canada N6C 2V5

2. University of Western Ontario; Department of Paediatrics; London ON Canada

3. Children's Hospital of Western Ontario; Department of Paediatrics; 800 Commissioner's Rd. E London Ontario Canada N6C 2V5

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005646.pub2/fullpdf

Reference46 articles.

1. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study;Bonfanti;Biomedicine & pharmacotherapy,2000

2. Trimethoprim-Sulfamethoxazole (TMP-SMZ) Dose Escalation versus Direct Rechallenge for Pneumocystis Carinii Pneumonia Prophylaxis in Human Immunodeficiency Virus-Infected Patients with Previous Adverse Reaction to TMP-SMZ;Leoung;The Journal of Infectious Diseases,2001

3. A Randomized, Pilot Trial Comparing Full Versus Escalating Dose Regimens for the Desensitization of AIDS Patients Allergic to Sulfonamides;Straatmann;The Brazilian Journal of Infectious Disease,2002

4. Efficacy and Safety of Desensitization to Trimethoprim-Sulfamethoxazole in Human Immunodeficiency Virus-Infected Patients;Picketty;The Journal of Infectious Disease,1995

5. Waugh W An open, randomised trial to compare desensitisation with rechallenge when restarting co-trimoxazole as prophylaxis against Pneumocystis carinii pneumonia (PCP) in patients with Human Immunodeficiency Virus (HIV) infection and a history of mild to moderate cutaneous and/or febrile reactions to co-trimoxazole (The COTOX trial) ISRCTN74775699

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pneumocystis jirovecii Pneumonia in a Liver Transplant Recipient With an Adverse Reaction to Trimethoprim/Sulfamethoxazole Treated With a Sulfonamide Desensitization Protocol: Case Report;Transplantation Proceedings;2024-05

2. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials;Clinical Microbiology and Infection;2024-04

3. Pneumocystis jirovecii pneumonia in people living with HIV: a review;Clinical Microbiology Reviews;2024-03-14

4. Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label;World Allergy Organization Journal;2024-01

5. Benzylated Sulfamethoxazole Derivatives with Improved Safety Profile as Potential Anti-Mycobacterium tuberculosis and Antibacterial Agents;Journal of Chemistry;2023-09-12